These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30057899)

  • 21. Lamins and lamin-binding proteins in functional chromatin organization.
    Gotzmann J; Foisner R
    Crit Rev Eukaryot Gene Expr; 1999; 9(3-4):257-65. PubMed ID: 10651242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
    Friesen M; Cowan CA
    Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
    Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reorganization of the nuclear architecture in the
    Bondarenko SM; Sharakhov IV
    Nucleus; 2020 Dec; 11(1):283-298. PubMed ID: 32960740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.
    Davies SJ; Ryan J; O'Connor PBF; Kenny E; Morris D; Baranov PV; O'Connor R; McCarthy TV
    Adipocyte; 2017 Oct; 6(4):259-276. PubMed ID: 28872940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LAP2alpha facilitates myogenic gene expression by preventing nucleoplasmic lamin A/C from spreading to active chromatin regions.
    Ferraioli S; Sarigol F; Prakash C; Filipczak D; Foisner R; Naetar N
    Nucleic Acids Res; 2024 Oct; 52(19):11500-11518. PubMed ID: 39228367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis.
    Naetar N; Foisner R
    Cell Cycle; 2009 May; 8(10):1488-93. PubMed ID: 19377295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology and Regulatory Roles of Nuclear Lamins in Cellular Function and Dysfunction.
    Khadija SG; Chen F; Hadden T; Commissaris RL; Kowluru A
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):111-20. PubMed ID: 26453024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
    Favreau C; Dubosclard E; Ostlund C; Vigouroux C; Capeau J; Wehnert M; Higuet D; Worman HJ; Courvalin JC; Buendia B
    Exp Cell Res; 2003 Jan; 282(1):14-23. PubMed ID: 12490190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear lamins: making contacts with promoters.
    Lund E; Collas P
    Nucleus; 2013; 4(6):424-30. PubMed ID: 24213377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathies.
    Camozzi D; Capanni C; Cenni V; Mattioli E; Columbaro M; Squarzoni S; Lattanzi G
    Nucleus; 2014; 5(5):427-40. PubMed ID: 25482195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of an integration-free induced pluripotent stem cell line (PUMCHi001-A) from a patient with familial partial lipodystrophy type 2 (FPLD2) carrying a heterozygous p.R349W (c.1045C > T) mutation in the LMNA gene.
    Xiao C; Yu M; Liu J; Wu H; Deng M; Zhang Q; Xiao X
    Stem Cell Res; 2020 Jan; 42():101651. PubMed ID: 31794942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
    Holt I; Clements L; Manilal S; Brown SC; Morris GE
    Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
    Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex effects of laminopathy mutations on nuclear structure and function.
    Ho R; Hegele RA
    Clin Genet; 2019 Feb; 95(2):199-209. PubMed ID: 30280378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping Nuclear Lamin-Genome Interactions by Chromatin Immunoprecipitation of Nuclear Lamins.
    Oldenburg AR; Collas P
    Methods Mol Biol; 2016; 1411():315-24. PubMed ID: 27147051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of Nuclear Lamin A/C Action as a Key to Tissue-Specific Regulation of Cellular Identity in Health and Disease.
    Malashicheva A; Perepelina K
    Front Cell Dev Biol; 2021; 9():761469. PubMed ID: 34722546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear peripheral chromatin-lamin B1 interaction is required for global integrity of chromatin architecture and dynamics in human cells.
    Chang L; Li M; Shao S; Li C; Ai S; Xue B; Hou Y; Zhang Y; Li R; Fan X; He A; Li C; Sun Y
    Protein Cell; 2022 Apr; 13(4):258-280. PubMed ID: 33155082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered protein dynamics of disease-associated lamin A mutants.
    Gilchrist S; Gilbert N; Perry P; Ostlund C; Worman HJ; Bickmore WA
    BMC Cell Biol; 2004 Dec; 5(1):46. PubMed ID: 15596010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
    Hegele RA; Cao H; Anderson CM; Hramiak IM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.